Article Text

Download PDFPDF
CASE REPORT
Extramammary Paget’s disease of the scrotum with complete response to imiquimod and photodynamic therapy
  1. Tyler M Bauman,
  2. Ilana S Rosman,
  3. David M Sheinbein
  1. Division of Dermatology, Washington University in St Louis School of Medicine, St Louis, Missouri, USA
  1. Correspondence to Dr David M Sheinbein, sheinbeind{at}wustl.edu

Summary

Extramammary Paget’s disease (EMPD) is a rare intraepithelial neoplasm with an extremely variable clinical course. The objective of this study was to determine if combination imiquimod and photodynamic therapy could induce remission of EMPD. A 69-year-old man with EMPD was treated with topical imiquimod 5% cream at night for 5 days per week for 1 month, followed by 2 months of 5% imiquimod for three nights a week. For the following 6 months, monthly 5-aminolevulinic acid photodynamic therapy was added. After 6 months, imiquimod was discontinued and the patient continued to be treated with quarterly photodynamic therapy. Treatment resulted in significant improvement in the appearance of the lesion, and pathology revealed no evidence of residual disease. The patient has had no clinical signs of disease for >5 years. We conclude that topical imiquimod 5% cream and photodynamic therapy may aid in the treatment of some patients with EMPD.

  • dermatology
  • immunology
  • prostate cancer

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Contributors TMB was responsible for writing the manuscript and making the figures. ISR was responsible for reading the pathology, acquiring images and reading and editing the final manuscript. DMS saw the patient in clinic, was responsible for the workup and diagnosis, read and edited the final manuscript and oversaw the project.

  • Funding This research received no specific grant from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient consent Obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.